Healthy Skepticism Library item: 3523

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Re: the promotion of lincomycin and clindamycin
1987 Oct;

Abstract:

Upjohn’s reply to the MaLAM letter about marketing of clindamycin and lincomycin still leaves a number of questions unanswered about Upjohn’s support for the IFPMA marketing code, for its compliance with Indian government regulations and about adverse effects associated with lincomycin and clindamycin.

Keywords:
*analysis/India/developing countries/Code of Pharmaceutical Marketing Practices (IFPMA)/ International Federation of Pharmaceutical Manufacturers Associations/ IFPMA/ MaLAM/ Medical Lobby for Appropriate Marketing/ quality of information/Lincocin/Dalacin C/PROMOTION AS A SOURCE OF INFORMATION: DOCTORS/REGULATION, CODES, GUIDELINES: COMPLIANCE, SANCTIONS, STANDARDS/REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION